She was shocked to be diagnosed with rectal cancer at 29 and had her reproductive organs temporarily moved out of her pelvis ...

When multiple members of a family have had cancer especially at young ages or at the same site, it can signal inherited risk ...

Natera, Inc. , a global leader in cell-free DNA and precision medicine, today announced the publication of findings from the randomized, phase III CALGB (Alliance)/SWOG 80702 study in JAMA Oncology.

A damning review has found there have been serious lapses in care for patients during surgery at the Queen Elizabeth Hospital ...

RASolute 304 is anticipated to enroll approximately 500 patients with PDAC harboring oncogenic RAS mutations who have undergone resection and completed perioperative chemotherapy. The trial will ...

Operations at the Queen Elizabeth Hospital in King's Lynn are being led by another NHS trust after a damning report revealed "lapses ...

Natera (NTRA) announced the publication of findings from the randomized, phase III CALGB/SWOG 80702 study in JAMA Oncology. This publication ...

The company says it can turn profits without its customers facing the usual out-of-pocket costs or high premiums. Economists ...

MDNA11 demonstrates durable anti-tumor activity in phase-2 eligible expansion cohorts, enriched for immune checkpoint resistant melanoma, MSS endometrial cancer, MSI-H and TMB-H cancers, in each case ...

Colorectal cancer, or CRC, is the world's second most lethal cancer based on the number of deaths, and is the third most ...